As such, even though our current understanding on the importance of MARCKS in the vasculature is only at its infancy, it is likely that MARCKS and its associated signaling pathways are legitimate future therapeutic targets for vascular diseases such as atherosclerosis, systemic and pulmonary hypertension, and sepsis. This evidence concerns the gene MARCKS and pulmonary arterial hypertension.